» Współczesne zagrożenia zakażeniami wirusowymi

*Tadeusz Płusa

Współczesne zagrożenia zakażeniami wirusowymi

Actual threats of viral infections

Wojskowy Instytut Medyczny, Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii CSK MON w Warszawie
Kierownik Kliniki: prof. dr hab. med. Tadeusz Płusa

Summary

Key words:

Piśmiennictwo

1. Ingesby TV et al.: Anthrax as a biological weapon. Medical and public health management. JAMA 1999; 18: 1735-1744. 2. Chomiczewski K: Współczesne poglądy na zagrożenie bronią biologiczną. Lek Wojsk 2002; 78/1: 5-9. 3. Franz DR et al.: Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278/5: 399-411. 4. Gall W, Grzybowski J: Wybrane zagadnienia dochodzenia epidemiologicznego w przypadkach militarnego lub terrorystycznego ataku biologicznego. [W:] Chomiczewski K, Grzybowski J, Gall W (red.): Epidemiologia działań wojennych i katastrof. α Medica Press, Biała Podlaska 2001; 66-82. 5. Holloway HC et al.: The treat of biological weapons. Prophylaxis and mitigation of psychological and social consequences. JAMA 1997; 278/5: 425-7. 6. Voelker R: Surviving Ebola. JAMA 1999; 281: 18. 7. Zaiki SR: A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread and surveillance of Ebola hemorrhagic fever. J Infect Dis 1999; 179/suppl. 1: S36-47. 8. Płusa T, Jahnz-Różyk K: Broń biologiczna. Medpress, Warszawa 2002. 9. Kallio-Kokko H et al.: Hantavirus and arenavirus antibody prevalence in rodents and humans in Trentino, Northern Italy. Epidemiol Infect 2005; 1-7: 21-5. 10. Tkachenko EA et al.: The epizootological and virological characteristics of a natural hantavirus infection focus in the subtropic zone of the Krasnodarsk Territory. Vopr Virusol 2005; 50/3: 14-9. 11. Kanerva M, Mustonen J, Vaheri A: Pathogenesis of Puumala and other Hantavirus infections. Rev Med Virol 1998; 8: 67-86. 12. Lednicky JA: Hantaviruses. A short review. Arch Pathol Lab Med 2003; 127: 30-35. 13. McCaughey C, Hart CA: Hantaviruses. J Med Microbiol 2000; 49: 587-599. 14. Douglass RJ, Calisher CH, Bradley KC: State-by-state incidences of hantavirus pulmonary syndrome in the United States, 1993-2004. Vector Borne Zoonotic Dis 2005; 5/2: 189-92. 15. Qiao G et al.: Analysis of part of M gene and genotyping for M segment of hantavirus detected from HFRS patients´ sera in Qingdao region during 2000-2003. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2005; 19/1: 22-4. 16. Tai PW, Chen LC, Huang CH: Hanta hemorrhagic fever with renal syndrome: a case report and review. J Microbiol Immunol Infect 2005; 38/3: 221-3. 17. Sandmann S et al.: Detection of human hantavirus infections in Lithuania. Infection 2005; 33/2: 66-72. 18. Severson W et al.: Essential amino acids of the hantaan virus N protein in its interaction with RNA. J Virol 2005; 79/15: 1032-9. 19. Strady C et al.: Hantavirus infections. Presse Med 2005; 34/5: 391-9. 20. Mailles A et al.: Increase of Hantavirus infections in France, 2003. Med Mal Infect 2005; 35/2: 68-72. 21. Khan AS, Kitsutani PT, Corneli AL: Hantavirus pulmonary syndrome in the Americas: the early years. Semin. Respir Crit Care Med 2000; 21/4: 313-22. 22. Cvetko L et al.: Puumala virus in Croatia in the 2002 HFRS outbreak. J Med Virol 2005; 77/2: 290-4. 23. Centers for Disease Control and Prevention: Update: outbreak of severe acute respiratory syndrome – worldwide 2003. MMWR Morb. Mortal Wkly Rep 52: 241-248. 24. de Jong MD et al.: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl J Med 2005; 353: 686-691. 25. Marra MA et al.: The genome sequence of the SARS-associated coronavirus. Science 2003; 300: 1399-1404. 26. Ruan Y-J et al.: Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003; 361: 1779-1785. 27. World Health Organisation: Acute respiratory syndrome in China – update 3: disease outbreak reported. Geneva: February 2003. (Accessed April 22, 2003, at http://www.who.int/csr/don/2003_2_20/en). 28. Peiris JSM et al.: Clinical progression and viral load in a community outbreak of coronaviruse-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767-1772. 29. World Health Organisation. Case definition for surveillance of severe acute respiratory syndrome (SARS). Revised 2003 May 1. Available: www.who.int/csr/sars/casedefinition/en. 30. Liu C-L et al.: Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 2004; 126: 509-517. 31. Wong SY, Yuen K-Y: Avian influenza virus infections in human. Chest 2006; 129/1: 156-168. 32. Poutanen SM, Low DE, Henry B: Idnetification of severe acute respiratory syndrome in Canada. NEJM 2003; 348: 1995-2005. 33. Perez D, Sorrell EM, Donis RO: Avian influenza. An omnipresent pandemic treat. Ped Infect Dis J 2005; 24/11: S208-S216. 34. Slemons RD, Easterday BC: Virus replication in the digestive tract of ducks exposed by aerosol to type A influenza. Avian Dis 1978; 22: 367-377. 35. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-1385. 36. Chotpitayasunondh T et al.: Human disease from influenza A (H5N1), Thailand, 2004. Emerg. Infect Dis 2005; 11: 201-209. 37. Tran TII et al.: Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188. 38. Rota PA et al.: Characterization of a novel coronavirus associated with the severe acute respiratory syndrome. Science 2003; 300: 1394-1399. 39. Spackman E et al.: Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002; 40: 3256-3260. 40. McKimm-Breschkin J et al.: Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother 2003; 47: 2264-2272. 41. Le QM et al.: Avian flu: isolation of drug-resistent H5N1 virus. Nature 2005; 437: 1108. 42. Liem NT, Lim W: World Health Organization International Avian Influenza Investigation Team, Vietnam. Lack of H5N1 avian influenza transmission to hospital employers, Hanoi, 2004. Emerg Infect Dis 2005; 11: 210-215. 43. Goroux JN: Generalites sur l´arme biologique. Med Arm 2001; 29/4: 381-93. 44. Mulic R, Ropac D: Epidemiologic characteristics and military implications of hemorrhagic fever with renal syndrome in Croatia. Croat Med J 2002; 43: 581-6.

otrzymano/received: 2009-08-23
zaakceptowano/accepted: 2009-09-02

Adres/address:
*Tadeusz Płusa
Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii CSK MON, WIM
ul. Szaserów 128, 00-909 Warszawa
e-mail: tplusa@wim.mil.pl

Pełna wersja artykułu Współczesne zagrożenia zakażeniami wirusowymi dostępna w Czytelni Medycznej Borgis.

Copyright © Wydawnictwo Medyczne Borgis Sp. z o.o. 2007-2013
Chcesz być na bieżąco? Polub nas na Facebooku: strona Wydawnictwa na Facebooku